Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity

Pedram Yadollahi1, You-Kyoung Jeon1, Wooi Loon Ng2

  • 1Innovative Therapeutic Research Institute, Inje University, Busan 47397; Department of Microbiology and Immunology, Inje University College of Medicine, Busan 47392, Korea.

BMB Reports
|December 10, 2020
PubMed

Insights

Programmed cell-death ligand 1 (PD-L1) has shown clinical success in cancer immunotherapy. Emerging research reveals PD-L1 also regulates cancer-intrinsic activities beyond immune response, impacting tumor progression.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cancer immunotherapies targeting the programmed cell-death 1 (PD-1) and programmed cell-death ligand 1 (PD-L1) pathway have achieved significant clinical success.
  • While PD-L1 is known for its role in immune regulation within the tumor microenvironment, recent studies highlight its non-immunological functions.

Purpose of the Study:

  • To review the current understanding of cancer-intrinsic programmed cell-death ligand 1 (PD-L1).
  • To explore the regulation of PD-L1 expression and its protumoral activities within cancer cells.

Main Methods:

  • Literature review of recent reports on PD-L1.
  • Analysis of studies investigating PD-L1's role in cancer-intrinsic processes.

Main Results:

  • PD-L1 plays a crucial role in immune regulation in the tumor microenvironment.
  • PD-L1 influences cancer-intrinsic activities such as epithelial-mesenchymal transition, metabolism, stemness, and autophagy.
  • Regulation of PD-L1 expression impacts its protumoral functions.

Conclusions:

  • PD-L1 exhibits significant non-immunological functions that promote cancer progression.
  • Understanding these intrinsic roles of PD-L1 is crucial for developing novel cancer therapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.3K